Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Why companies left AIM in February 2023

Dekel Agri-Vision volumes could improve in March

Further progress at MTI Wireless

M7 Box+ REIT set to join IPSX in April

AIM movers: Condor Gold progresses La India sale and Aferian continues fall

Aquis weekly movers: Six companies with rising share prices

Town Centre discount

UK companies that have relationships with Silicon Valley Bank

AIM weekly movers: Celadon Pharmaceuticals share price recovery

AIM movers: Tintra subscription and Aferian hit by destocking

AIM movers: Atlantic Lithium refutes short-selling claims and ex-dividends

Flat revenues at Somero Enterprises

Cloud accelerates Netcall progress

Breedon plans premium move

AIM movers: Time Finance gains momentum and Midatech Pharma to leave AIM

AIM movers: In The Style selling business and K3 Business retail contract

Dotdigital invests for the future

Shaftesbury Capital formed after merger

AIM movers: Amur Minerals sells Russian project and Pantheon Resources loses investor confidence

Aquis weekly movers: Western Selection stake

AIM weekly movers: i-nexus Global bounces back

AIM movers: Active Energy trademark and Longboat Energy partners relinquish licence

AIM movers: Poolbeg Pharma clinical trial success and ex-dividends

AIM movers: T42 IOT shipping container focus and Inland Homes resignations

AIM movers: Safestay occupancy recovers and Baron Oil disappoints

AIM movers: i-nexus Global gains customers and discounted Hercules placing

Tip update: Transense Technologies builds its cash pile

Aquis weekly movers: Marula Mining increases Kinusi stake

AIM weekly movers: Destiny Pharma secures partner but discounted placing hits share price

CVS Group like-for-like growth at top of target range

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020